590 related articles for article (PubMed ID: 29633372)
1. Evaluating the predictive accuracy and the clinical benefit of a nomogram aimed to predict survival in node-positive prostate cancer patients: External validation on a multi-institutional database.
Bianchi L; Schiavina R; Borghesi M; Bianchi FM; Briganti A; Carini M; Terrone C; Mottrie A; Gacci M; Gontero P; Imbimbo C; Marchioro G; Milanese G; Mirone V; Montorsi F; Morgia G; Novara G; Porreca A; Volpe A; Brunocilla E
Int J Urol; 2018 Jun; 25(6):574-581. PubMed ID: 29633372
[TBL] [Abstract][Full Text] [Related]
2. Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.
Gandaglia G; Fossati N; Zaffuto E; Bandini M; Dell'Oglio P; Bravi CA; Fallara G; Pellegrino F; Nocera L; Karakiewicz PI; Tian Z; Freschi M; Montironi R; Montorsi F; Briganti A
Eur Urol; 2017 Oct; 72(4):632-640. PubMed ID: 28412062
[TBL] [Abstract][Full Text] [Related]
3. A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.
Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Fossati N; Stabile A; Beauval JB; Malavaud B; Roumiguié M; Robesti D; Dell'Oglio P; Moschini M; Zamboni S; Rakauskas A; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
Eur Urol; 2019 Mar; 75(3):506-514. PubMed ID: 30342844
[TBL] [Abstract][Full Text] [Related]
4. Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement.
Godoy G; Chong KT; Cronin A; Vickers A; Laudone V; Touijer K; Guillonneau B; Eastham JA; Scardino PT; Coleman JA
Eur Urol; 2011 Aug; 60(2):195-201. PubMed ID: 21257258
[TBL] [Abstract][Full Text] [Related]
5. Assessing the clinical benefit of a nomogram to predict specimen-confined disease at radical prostatectomy in patients with high-risk prostate cancer: An external validation.
Hansen J; Becker A; Kluth LA; Rink M; Steuber T; Zacharias M; Briganti A; Fisch M; Graefen M; Chun FK
Urol Oncol; 2015 Sep; 33(9):384.e1-8. PubMed ID: 26122714
[TBL] [Abstract][Full Text] [Related]
6. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
[TBL] [Abstract][Full Text] [Related]
7. External validation of the Briganti nomogram to estimate the probability of specimen-confined disease in patients with high-risk prostate cancer.
Roumiguié M; Beauval JB; Filleron T; Benoit T; Rischmann P; de la Taille A; Salomon L; Soulié M; Malavaud B; Ploussard G
BJU Int; 2014 Dec; 114(6b):E113-E119. PubMed ID: 24684584
[TBL] [Abstract][Full Text] [Related]
8. External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection.
Gandaglia G; Martini A; Ploussard G; Fossati N; Stabile A; De Visschere P; Borgmann H; Heidegger I; Steinkohl F; Kretschmer A; Marra G; Mathieu R; Surcel C; Tilki D; Tsaur I; Valerio M; Van den Bergh R; Ost P; Gontero P; Montorsi F; Briganti A;
Eur Urol; 2020 Aug; 78(2):138-142. PubMed ID: 32268944
[TBL] [Abstract][Full Text] [Related]
9. External validation of nomogram predicting the probability of specimen-confined disease (pT2-3a, R0N0) in patients undergoing radical prostatectomy and pelvic lymph node dissection.
Mearini L; Gacci M; Saleh O; De Nunzio C; Schiavina R; Simonato A; Tubaro A; Carmignani G; Mirone V; Carini M; Bini V; Porena M;
Urol Int; 2014; 93(3):262-8. PubMed ID: 24356093
[TBL] [Abstract][Full Text] [Related]
10. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.
Briganti A; Larcher A; Abdollah F; Capitanio U; Gallina A; Suardi N; Bianchi M; Sun M; Freschi M; Salonia A; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2012 Mar; 61(3):480-7. PubMed ID: 22078338
[TBL] [Abstract][Full Text] [Related]
11. Validation of nomograms predicting lymph node involvement in patients with prostate cancer undergoing extended pelvic lymph node dissection.
Hinev AI; Anakievski D; Kolev NH; Hadjiev VI
Urol Int; 2014; 92(3):300-5. PubMed ID: 24480972
[TBL] [Abstract][Full Text] [Related]
12. Predicting survival of men with recurrent prostate cancer after radical prostatectomy.
Dell'Oglio P; Suardi N; Boorjian SA; Fossati N; Gandaglia G; Tian Z; Moschini M; Capitanio U; Karakiewicz PI; Montorsi F; Karnes RJ; Briganti A
Eur J Cancer; 2016 Feb; 54():27-34. PubMed ID: 26707594
[TBL] [Abstract][Full Text] [Related]
13. Predictive accuracy and clinical benefit of a nomogram aimed to predict
Bianchi L; Borghesi M; Schiavina R; Castellucci P; Ercolino A; Bianchi FM; Barbaresi U; Polverari G; Brunocilla E; Fanti S; Ceci F
Eur J Nucl Med Mol Imaging; 2020 Aug; 47(9):2100-2105. PubMed ID: 32006061
[TBL] [Abstract][Full Text] [Related]
14. Development and External Validation of a Novel Nomogram to Predict the Probability of Pelvic Lymph-node Metastases in Prostate Cancer Patients Using Magnetic Resonance Imaging and Molecular Imaging with Prostate-specific Membrane Antigen Positron Emission Tomography.
Vis AN; Meijer D; Roberts MJ; Siriwardana AR; Morton A; Yaxley JW; Samaratunga H; Emmett L; van de Ven PM; Heymans MW; Nieuwenhuijzen JA; van der Poel HG; Donswijk ML; Boellaard TN; Schoots IG; Stricker P; Haynes AM; Oprea-Lager DE; Coughlin GD; van Leeuwen PJ
Eur Urol Oncol; 2023 Dec; 6(6):553-563. PubMed ID: 37045707
[TBL] [Abstract][Full Text] [Related]
15. Multicenter External Validation of a Nomogram for Predicting Positive Prostate-specific Membrane Antigen/Positron Emission Tomography Scan in Patients with Prostate Cancer Recurrence.
Bianchi L; Castellucci P; Farolfi A; Droghetti M; Artigas C; Leite J; Corona P; Shagera QA; Moreira R; González C; Queiroz M; de Galiza Barbosa F; Schiavina R; Deandreis D; Fanti S; Ceci F
Eur Urol Oncol; 2023 Feb; 6(1):41-48. PubMed ID: 34933814
[TBL] [Abstract][Full Text] [Related]
16. Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy.
Abdollah F; Schmitges J; Sun M; Thuret R; Djahangirian O; Tian Z; Shariat SF; Briganti A; Perrotte P; Montorsi F; Karakiewicz PI
Urology; 2011 Dec; 78(6):1363-7. PubMed ID: 22137704
[TBL] [Abstract][Full Text] [Related]
17. External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection.
Hansen J; Rink M; Bianchi M; Kluth LA; Tian Z; Ahyai SA; Shariat SF; Briganti A; Steuber T; Fisch M; Graefen M; Karakiewicz PI; Chun FK
Prostate; 2013 Jan; 73(2):211-8. PubMed ID: 22821742
[TBL] [Abstract][Full Text] [Related]
18. Predicting pathological outcomes in patients undergoing robot-assisted radical prostatectomy for high-risk prostate cancer: a preoperative nomogram.
Abdollah F; Klett DE; Sood A; Sammon JD; Pucheril D; Dalela D; Diaz M; Peabody JO; Trinh QD; Menon M
BJU Int; 2015 Nov; 116(5):703-12. PubMed ID: 25413443
[TBL] [Abstract][Full Text] [Related]
19. Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer.
Hessman CJ; Naik AM; Kearney NM; Jensen AJ; Diggs BS; Troxell ML; Vetto JT
Arch Surg; 2011 Sep; 146(9):1035-40. PubMed ID: 21931000
[TBL] [Abstract][Full Text] [Related]
20. External validation of the European association of urology recommendations for pelvic lymph node dissection in patients treated with robot-assisted radical prostatectomy.
Dell'Oglio P; Abdollah F; Suardi N; Gallina A; Cucchiara V; Vizziello D; Zaffuto E; Cantiello F; Damiano R; Shariat S; Montorsi F; Briganti A
J Endourol; 2014 Apr; 28(4):416-23. PubMed ID: 24188052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
